These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 32573008

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
    Makhaeva GF, Lushchekina SV, Boltneva NP, Serebryakova OG, Rudakova EV, Ustyugov AA, Bachurin SO, Shchepochkin AV, Chupakhin ON, Charushin VN, Richardson RJ.
    Bioorg Med Chem; 2017 Nov 01; 25(21):5981-5994. PubMed ID: 28986116
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Search for new multi-target compounds against Alzheimer's disease among histamine H3 receptor ligands.
    Bajda M, Łażewska D, Godyń J, Zaręba P, Kuder K, Hagenow S, Łątka K, Stawarska E, Stark H, Kieć-Kononowicz K, Malawska B.
    Eur J Med Chem; 2020 Jan 01; 185():111785. PubMed ID: 31669851
    [Abstract] [Full Text] [Related]

  • 8. Design and synthesis of new carbamates as inhibitors for fatty acid amide hydrolase and cholinesterases: Molecular dynamic, in vitro and in vivo studies.
    Maleki MF, Nadri H, Kianfar M, Edraki N, Eisvand F, Ghodsi R, Mohajeri SA, Hadizadeh F.
    Bioorg Chem; 2021 Apr 01; 109():104684. PubMed ID: 33607363
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer's Disease.
    Yu YF, Huang YD, Zhang C, Wu XN, Zhou Q, Wu D, Wu Y, Luo HB.
    ACS Chem Neurosci; 2017 Nov 15; 8(11):2522-2534. PubMed ID: 28783948
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease Agents.
    Montanari S, Scalvini L, Bartolini M, Belluti F, Gobbi S, Andrisano V, Ligresti A, Di Marzo V, Rivara S, Mor M, Bisi A, Rampa A.
    J Med Chem; 2016 Jul 14; 59(13):6387-406. PubMed ID: 27309570
    [Abstract] [Full Text] [Related]

  • 15. Novel Cyclopentaquinoline and Acridine Analogs as Multifunctional, Potent Drug Candidates in Alzheimer's Disease.
    Maciejewska K, Czarnecka K, Kręcisz P, Niedziałek D, Wieczorek G, Skibiński R, Szymański P.
    Int J Mol Sci; 2022 May 24; 23(11):. PubMed ID: 35682556
    [Abstract] [Full Text] [Related]

  • 16. Graveoline Analogs Exhibiting Selective Acetylcholinesterase Inhibitory Activity as Potential Lead Compounds for the Treatment of Alzheimer's Disease.
    Li Z, Mu C, Wang B, Jin J.
    Molecules; 2016 Jan 22; 21(2):132. PubMed ID: 26805806
    [Abstract] [Full Text] [Related]

  • 17. Exploiting the Chalcone Scaffold to Develop Multifunctional Agents for Alzheimer's Disease.
    Rampa A, Bartolini M, Pruccoli L, Naldi M, Iriepa I, Moraleda I, Belluti F, Gobbi S, Tarozzi A, Bisi A.
    Molecules; 2018 Jul 30; 23(8):. PubMed ID: 30061534
    [Abstract] [Full Text] [Related]

  • 18. Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer's disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation.
    Makhaeva GF, Kovaleva NV, Boltneva NP, Lushchekina SV, Rudakova EV, Stupina TS, Terentiev AA, Serkov IV, Proshin AN, Radchenko EV, Palyulin VA, Bachurin SO, Richardson RJ.
    Bioorg Chem; 2020 Jan 30; 94():103387. PubMed ID: 31735356
    [Abstract] [Full Text] [Related]

  • 19. Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease.
    Li Y, Qiang X, Li Y, Yang X, Luo L, Xiao G, Cao Z, Tan Z, Deng Y.
    Bioorg Med Chem Lett; 2016 Apr 15; 26(8):2035-9. PubMed ID: 26947607
    [Abstract] [Full Text] [Related]

  • 20. Development of cyanopyridine-triazine hybrids as lead multitarget anti-Alzheimer agents.
    Maqbool M, Manral A, Jameel E, Kumar J, Saini V, Shandilya A, Tiwari M, Hoda N, Jayaram B.
    Bioorg Med Chem; 2016 Jun 15; 24(12):2777-88. PubMed ID: 27157006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.